Fig. 4From: Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeysLocal effects on ovarian angiogenic factors by VEGFA neutralization in COS cycles. Intrafollicular VEGFA (a), and LGC production of VEGFA (b), progesterone (P4; c), ANGPT1 (d), ANGPT2 (e), and ratio of ANGPT2:1 (f) as detected in media after 24Â h of culture in aspirates from control COS and anti-VEGFA (Avastin) treated females. See Methods for further details. Different uppercase letters indicate significant (PÂ <Â 0.05) differences between Control and Avastin Pre-CG treatment groupsBack to article page